Onfi

Chemical Nameclobazam
Dosage FormTablet (oral; 10 mg, 20 mg); Suspension (oral; 2.5 mg/mL)
Drug ClassBenzodiazepines
SystemNervous
CompanyLundbeck
Approval Year2011

Indication

  • For the adjunctive treatment of seizures associated with Lennox-Gastaut syndrome (LGS) in patients 2 years of age or older.
Last updated on 1/11/2023

More on this drug: Clinical Trials

Document TitleYearSource
Onfi (clobazam) Prescribing Information.2021Lundbeck, Deerfield, IL
Document TitleYearSource
Anti-seizure medications for Lennox-Gastaut syndrome.2021The Cochrane Database of Systematic Reviews
Clobazam monotherapy for focal or generalized seizures.2018The Cochrane Database of Systematic Reviews
Systematic review of clobazam use in patients with status epilepticus.2018Epilepsia Open
Prophylactic drug management for febrile seizures in children.2017The Cochrane Database of Systematic Reviews
Document TitleYearSource
Practice guideline update summary: efficacy and tolerability of the new antiepileptic drugs II: treatment-resistant epilepsy.2018American Academy of Neurology and the American Epilepsy Society